Sugi Predict

Sugi Predict / Compounds / SCHEMBL900450

SCHEMBL900450

SCHEMBL900450

COc1c(Cl)ccnc1C

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAOA P21397 3/20 0.48
▸ ALDH1A1 P00352 4/20 0.38
▸ KDM4E B2RXH2 2/20 0.38
▸ HSD17B10 Q99714 2/20 0.38
▸ DYRK1A Q13627 4/20 0.35
▸ CCR1 P32246 1/20 0.34
▸ CCR5 P51681 1/20 0.34
▸ CCR8 P51685 1/20 0.34
▸ KMT2A Q03164 1/20 0.34
▸ CCNT1 O60563 2/20 0.34
▸ CDK9 P50750 2/20 0.34
▸ ADRA1A P35348 1/20 0.34
▸ HPGD P15428 3/20 0.33
▸ HASPIN Q8TF76 2/20 0.33
▸ DYRK2 Q92630 2/20 0.33
▸ ACHE P22303 2/20 0.33
▸ HTR2C P28335 2/20 0.33
▸ HTR7 P34969 2/20 0.33
▸ DYRK3 O43781 1/20 0.33
▸ CCNB2 O95067 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30230932 1.00 MAOA (0.48) MAOAALDH1A1KDM4EHSD17B10DYRK1A
SCHEMBL3170730 0.86 MAOA (0.37) MAOACYP2A6
SCHEMBL11755564 0.80 ALDH1A1 (0.39) MAOAALDH1A1KDM4EHSD17B10DYRK1A
SCHEMBL4573388 0.79 ALDH1A1 (0.40) MAOAALDH1A1KDM4EHSD17B10HPGD
SCHEMBL9267937 0.79 MAOA (0.40) MAOAALDH1A1KDM4EHSD17B10DYRK1A
SCHEMBL9267934 0.79 MAOA (0.35) MAOAADRA1AHASPINDYRK2ADRA2A
SCHEMBL9260347 0.77 SMN1; SMN2 (0.40) MAOAALDH1A1KDM4EHSD17B10DYRK1A
SCHEMBL10819312 0.77 MAOA (0.52) MAOAALDH1A1KDM4EHSD17B10DYRK1A
SCHEMBL22235846 0.77 DYRK1A (0.41) MAOAALDH1A1KDM4EHSD17B10DYRK1A
SCHEMBL31395266 0.77 DYRK1A (0.41) MAOAALDH1A1KDM4EHSD17B10DYRK1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 89 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-112028821-A Synthetic method of 2-methyl-3-methoxy-4-chloropyridine 安徽金禾实业股份有限公司 2020-12-04 — — CN claimed
CN-111978246-A Purification synthesis method of 2-methyl-3-methoxy-4-chloropyridine 安徽金禾实业股份有限公司 2020-11-24 — — CN claimed
CN-107129466-B Synthesis method of 4-chloro-3-methoxy-2-methylpyridine-N-oxide 滁州学院 2020-11-13 — — CN claimed
CN-110724090-A Method for heating pyridinium B3 chlorination reaction 安徽金禾实业股份有限公司 2020-01-24 — — CN claimed
CN-102020637-B Preparation method of 5-difluoromethoxy-2-[[(3,4-dimethoxy-2-pyridyl)methyl]thio]-1H-benzimidazole ZHEJIANG HUAYI PHARMACEUTICAL CO LTD 2014-09-10 — — CN claimed
CN-102020637-A Preparation method of 5-difluoromethoxy-2-[[(3,4-dimethoxy-2-pyridyl)methyl]thio]-1H-benzimidazole ZHEJIANG HUAYI PHARMACEUTICAL CO LTD 2011-04-20 — — CN claimed
EP-1335913-B1 A PROCESS FOR THE PREPARATION OF PANTOPRAZOLE AND INTERMEDIATES THEREFOR DINAMITE DIPHARMA SPA (IT) 2004-09-08 — — EP claimed
US-12590090-B2 Pyrimidine-and nitrogen-containing bicyclic compound ASAHI KASEI PHARMA CORPORATION (JP) 2026-03-31 — — US disclosed
EP-4223750-B1 NITROGEN-CONTAINING BICYCLIC COMPOUNDS WHICH CONTAIN PYRIMIDINE AS INTERLEUKIN 1 RECEPTOR-ASSOCIATED KINASE 4 (IRAK-4) INHIBITORS TO BE USED IN THE TREATMENT OF INFLAMMATORY OR AUTOIMMUNE DISEASES ASAHI KASEI PHARMA CORP (JP) 2025-06-25 — — EP disclosed
CN-116194454-B Pyrimidine-containing nitrogen-containing bicyclic compounds 旭化成制药株式会社 2025-02-18 — — CN disclosed
US-20240025893-A1 PYRIMIDINE-AND NITROGEN-CONTAINING BICYCLIC COMPOUND ASAHI KASEI PHARMA CORPORATION (JP) 2024-01-25 — — US disclosed
US-20230286943-A1 IL-17A MODULATORS SANOFI (FR) 2023-09-14 — — US disclosed
EP-4223750-A1 NITROGEN-CONTAINING BICYCLIC COMPOUND WHICH CONTAINS PYRIMIDINE Asahi Kasei Pharma Corporation (JP) 2023-08-09 — — EP disclosed
WO-1995007891-A1 SUBSTITUTED PYRIDINES, PROCESS FOR PRODUCING THEM AND THEIR USE AS PESTICIDES AND FUNGICIDES HOECHST SCHERING AGREVO GMBH (DE) 1995-03-23 — — WO disclosed
EP-0208452-B1 PYRIDINE DERIVATIVES, THEIR PRODUCTION AND USE Takeda Chemical Industries, Ltd. (JP) 1991-09-18 — — EP disclosed
EP-0390842-A1 NOVEL BENZIMIDAZOLE DERIVATIVES Byk Gulden Lomberg Chemische Fabrik GmbH (DE) 1990-10-10 — — EP disclosed
WO-1989005299-A1 NOVEL BENZIMIDAZOLE DERIVATIVES BYK GULDEN LOMBERG CHEMISCHE FABRIK GMBH (DE) 1989-06-15 — — WO disclosed
EP-0304732-A2 Substituted thienoimidazole derivatives, process for their preparation, pharmaceutical compositions containing them and their use as gastric secretion inhibitors HOECHST AKTIENGESELLSCHAFT (DE) 1989-03-01 — — EP disclosed
US-4738975-A Pyridine derivatives, and use as anti-ulcer agents TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 1988-04-19 — — US disclosed
EP-0208452-A2 Pyridine derivatives, their production and use Takeda Chemical Industries, Ltd. (JP) 1987-01-14 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240025893-A1 PYRIMIDINE-AND NITROGEN-CONTAINING BICYCLIC COMPOUND IRAK4, IRAK1, IRAK2 MAOA 3456/4885ALDH1A1 2898/4885KDM4E 624/4885
US-20230286943-A1 IL-17A MODULATORS IL17A, IL2, IL15 MAOA 2811/4885ALDH1A1 485/4885KDM4E 1898/4885
US-12590090-B2 Pyrimidine-and nitrogen-containing bicyclic compound IRAK1, IRAK4, IRAK2 MAOA 3297/4885ALDH1A1 3202/4885KDM4E 1029/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.